For someone experiencing cardiac symptoms in the emergency room, every minute matters as physicians determine whether someone is having a...
A new study published in The Lancet Neurology demonstrates the ability of two blood-based biomarkers to predict how someone will recover from traumatic brain injury (TBI)
Abbott announced that a new study, published in Lancet Neurology, found that elevated levels of a protein measured with the...
The stresses of life have long been thought to increase a person's risk of heart disease. But the question remains...
With a growing movement toward use of targeted therapies, parallel to psoriasis, JAK inhibitors are an important focus of therapeutic research for AD.
Alopecia Areata (AA) is a common autoimmune disease characterized by non-scarring hair loss ranging from patches on the scalp to complete hair loss involving the entire body.
Despite the availability of effective therapeutics and evidence-based treatment guidelines, a substantial proportion of patients with moderate-to-severe psoriasis does not receive appropriate care.
Echo Therapeutics, Inc. announced positive results from its clinical trial of the Symphony tCGM System in major general surgery and...
The main objective of the study was to evaluate the efficacy and safety of dabrafenib alone or combined with trametinib for compassionate use in patients with metastatic melanoma.
Hepion Pharmaceuticals, Inc. announced that it has begun wind-down activities in its ASCEND-NASH trial, while continuing to explore strategic alternatives, as previously announced in December 2023.